Oculus secures U.S. patent for skin ulcer technology

12/28/2012 | MedCityNews.com

Oculus Innovative Sciences has received a U.S. patent for its Microcyn Technology to be used in treating patients with skin ulcers. The technology is administered to skin ulcers either by irrigation, soaking and washing, or by applying a wound dressing that has been soaked with the technology.

View Full Article in:

MedCityNews.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY